Kevin Luke, MD
Orthopaedic Surgery · Palos Heights, ILNPI 1437157443
Payments from drug & device makers
Across 159 payments — averaging $380.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$48K
- Zimvie Inc.$11K
- Medical Device Business Services, Inc.$559
- Pacira Therapeutics, Inc.$295
- Johnson & Johnson$139
- DJO, LLC$112
- plus $304 from 8 others
What the payments were for
- Consulting fees$38,01563%
- Speaking & faculty fees$9,86316%
- Travel & lodging$9,82716%
- Food & beverage$2,7195%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 107 | $47,698 |
| Zimvie Inc. | 12 | $11,317 |
| Medical Device Business Services, Inc. | 3 | $559 |
| Pacira Therapeutics, Inc. | 16 | $295 |
| Johnson & Johnson | 5 | $139 |
| DJO, LLC | 3 | $112 |
| Stryker(2 entities) | 3 | $88 |
| Heron Therapeutics, Inc. | 2 | $48 |
| Carbofix Orthopedics Inc | 1 | $43 |
| Vertex | 2 | $33 |
| Orthofix Medical, Inc. | 2 | $31 |
| Bioventus LLC | 1 | $26 |
| Davol Inc. | 1 | $22 |
| Heraeus Medical, LLC. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biomet Orthopak$18,500
- EBI OsteoGen Implantable Bone Growth Stimulator$10,425
- PIB$6,625
- Bone Healing Product Portfolio$5,365
- AccuFill$811
- VA-LCP PLATES & SCREWS$515
- TFN ADVANCED$515
- Biomet EBI Bone Healing System$371
- ROSA-Knee$256
- Persona$141
- ROSA$110
How this compares
$60,425 in reported general payments places this provider in the 85th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $21,308 |
| Nabumetone | 258 | $2,714 |
| Meloxicam | 672 | $2,233 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 154 | $1,999 |
| Celecoxib | 75 | $1,609 |
| Lidocaine | 32 | $1,504 |
| Etodolac | 55 | $1,188 |
| Scopolamine | 33 | $483 |
| Diclofenac Sodium | 14 | $316 |
| Amoxicillin | 193 | $240 |
| Pregabalin | 39 | $174 |
| Ibuprofen | 19 | $167 |
| Tramadol Hcl | 36 | $133 |
| Clindamycin Hcl | 83 | $119 |
| Cephalexin | 44 | $115 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Palos Heights
- Paul DefrinoPalos Heights$253K
- Peter BonuttiEffingham$24.3M
- Steven HaddadGlenview$12.6M
- Aaron RosenbergChicago$12.4M
- Treg BrownHerrin$6.6M
- Kamal IbrahimOakbrook Terrace$4.9M
- Wayne GoldsteinMorton Grove$4.9M
- Steven MatherDowners Grove$4.3M
- Steven MardjetkoMorton Grove$4.3M
- Steven ChudikWestmont$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.